Radioimmunoguided surgery for colorectal carcinoma

Hepato-Gastroenterology

Volumn 46, Issue 26, 1999, Pages 691-700

  Filez, L ^a   Penninckx, F ^b   Ectors, N ^b   Van Cutsem, E ^b   Geboes, K ^b   Aerts, R ^b   D'Hoore, A ^b   Kerremans, R ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

Cancer; Colon tumor; Rectal tumor; Surgery

Indexed keywords

MONOCLONAL ANTIBODY; RADIOISOTOPE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; COLON; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RADIOIMMUNODETECTION; RECTUM; SENSITIVITY AND SPECIFICITY;

EID: 0032929659     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. 1 Aitken DR, Hinkle Thurston MO, et al: A gamma detecting probe for radioimmunodetection of CEA producing tumours. Dis Col Rec 1984; 27:279-282.
2. 2 Martin DT, Aitken D, Thurston M, et al: Successful experimental use of a self contained gamma detecting devise. Curr Surg 1984; 41:193-194.
3. 3 Wangensteen OH, Lewis FJ, Tongen LA: The 'second-look' in cancer surgery. Lancet 1951; 71:303-307.
4. 4 Wangensteen OH, Lewis FJ, Arhelger SW, et al: An interim report upon the 'second-look' procedure for cancer of the stomach, colon and rectum for 'limited' intraperitoneal carcinosis. Surg Gynaec Obst 1954; 99:257-267.
5. 5 Chu DZJ, Frische HA, Lang NP, et al: Resection of recurrent colorectal carcinoma: improved survival with CEA directed second-look laparotomy. J Tumour Mark Oncol 1987; 2:27-39.
6. 6 Minton JP, Hoehn JL, Gerber DM, et al: Results of a 400 patient carcinoembryonic antigen second-look colorectal cancer. Surgery 1985; 55:1284-1290.
7. 7 Martin EW, James KK, Hurtubise PE, et al: The use of CEA as an early indicator of gastrointestinal tumour recurrence and second-look procedures. Cancer 1977; 39:440-446.
8. 8 Sardi A, Agnone CM, Neiroda Ca, et al: Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computed tomography and physical examination. South Med J 1989; 82:1235-1244.
9. 9 Sugarbaker PH: Role of CEA in the management of cancer. Adv Immun-cancer Ther 1985; 1:167-193.
10. 10 Stevenson GW: Radiology and endoscopy in the pretreatment diagnostic management of colorectal cancer. Cancer 1993; 71:4198-4205.
11. 11 Kelvin FM, Korobkin M, Heaston DK, et al: The pelvis after surgery for colorectal carcinomas: serial CT observations with emphasis on non-neoplastic features. Am J Radiol 1983; 141:959-964.
12. 12 Hawes RH: New staging techniques: endoscopic ultrasound. Cancer 1993; 71:4207-4213.
13. 13 Theoni RF: Colorectal cancer: cross sectional imaging for staging of primary tumour and detection of local recurrence. Am J Radiol 1991; 156:909-916.
14. 14 Back WF, Contrera MA, Grady ED: Factors influencing localisation of antibodies in tumours. Cancer Res 1984; 40:2965-2972.
15. 15 Rollo FD, Patton JA: Imaging techniques for radioimmunodetection of cancer. Cancer Res 1980; 40:3050-3032.
16. 16 Roscoff SD, Goodenough DJ, McIntire KR: Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning. Cancer Res 1980; 40:3054-3058.
17. 17 Johnson VG, Schlom J, Paterson AJ, et al: Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986; 46:850-857.
18. 18 Thor A, Ohuchi N, Szpak Ca, et al: The distribution of oncofetal antigen TAG-72 defined by monoclonal antibody B72.3. Cancer Res 1986; 46:3118-3124.
19. 19 Thor A, Viglione MJ, Muraro R, et al: Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int J Gynaec Pathol 1987; 6:235-247.
20. 20 Wolf BC, D'Emilia JC, Salem RR, et al: Detection of the tumour associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon. J Natl Cancer Insti 1989; 81:1913.
21. 21 Lottich SC, Szpak CA, Johnson WW, et al: Phenotypic heterogeneity of a tumour associated antigen in adenocarcinoma of colon and their metastasis as demonstrated by monoclonal antibody B72.3. Cancer Invest 1986; 4:387-455.
22. 22 Schlom J: Basic principles and applications of monoclonal antibodies in the management of carcinomas. Cancer Res 1986; 46:3225-3238.
23. 23 Jain KR, Baxter LT: Mechanisms of heterogenous distribution of monoclonal antibodies and other macromolecules in tumours: significance of elevated interstitial pressure. Cancer Res. 1988; 48:7022-7032.
24. 24 Sheer DG, Schlom J, Cooper HL: Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res 1988; 48:6811-6818.
25. 25 Haboubi NY, Clark P, Kaftan SM, et al: The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 1992; 85:386-388.
26. 26 Scott KW, Grace RH: Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989; 76:1165-1167.
27. 27 Fujimaki M, Soga J, Wada K, Tani H, Aizawa O, Kawaguchi M, et al: Total gastrectomy for gastric cancer. Cancer 1972; 30:660-664.
28. 28 Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stule JP, Mittelman A: Metastases in small lymph nodes from colon cancer. Arch Surg 1987; 122:1253-1256.
29. 29 Grinell RS: The lymphatic and venous spread of carcinoma of the rectum. Ann Surg 1942; 116:200-216.
30. 30 Pickren JW: Nodal clearance and detection. JAMA 1975; 231:969-971.
31. 31 Nabi HA, Doerr RJ, Balu D, et al: Gamma probe assisted ex vivo detection of small lymph node metastases following the administration of indium-11-labeled monoclonal antibodies to colorectal cancers. J Nucl Med 1993; 34:1818-1822.
32. 125I-labeled monoclonal antibody. Proc AACR 1992; 33:317.
33. 33 Huvos AG, Hutter RVP, Berg JW: Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971; 173:44-51.
34. 34 Cutait R, Alves VAF, Lopes LC, et al: Restaging of colorectal cancer based on the identification of lymph node micrometastasis through immunoperoxidase staining of CEA and cytokeratins. Dis Col Rect 1991; 34:717-720.
35. 35 Greenson JK, Isenhart CE, Rice R, et al: Identification of occult micrometastasis in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: correlation with long-term survival. Cancer 1994; 73:563-569.
36. 36 Hayashi N, Arakawa H, Nagase H et al: Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathologic method. Cancer Res 1994; 54:3853-3856.
37. 37 Arnold MW, Hitchcock CL, Young DC, Burak WE, Bertsch DJ, Martin EW: Intra-abdominal patterns of disease dissimination in colorectal cancer identified using radioimmunoguided surgery. Dis Col Rect 1996; 39:509-513.
38. 38 Morson BC, Dawson IMP, Day DW, Jass JR, Price AB, Williams GR: Malignant epithelial tumours: In: Morson BC, Dawson IMP, Day DW, Jass JR, Price AB, Williams GR (Eds.). Morson and Dawson's gastrointestinal pathology. London: Blackwell Scientific Publications, 1990; pp. 597-629.
39. 39 Gabriel WB, Dukes C, Bussey HJR: Lymphatic spread in cancer of rectum. Br J Surg 1935; 23:395-413.
40. 40 Wolmark N, Fisher B, Weiand HS: The prognostic value of the modifications of the Dukes' C class of colorectal cancer. Ann Surg 1986; 203:115-121.
41. 41 Lange MK, Sandhu A, Sampsel J, Hinkle G, Ignaszewski J, Martin E, Sandhu P, Martin EW Jr: Evaluation of NR-LU-10 with the Neoprobe gamma detector in a mouse model. J Surg Res 1993; 55:205-213.
42. 42 Paganelli G, Stella M, Zito F, Magnani P, De Nardi P, Mangili F, Baratti D, Veglia F, Di Carlo V, Siccardi AG, et al: Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med 1994; 35:1970-1975.
43. 43 Stella M, De nardi P, Paganelli G, Magnani P, Mangili F, Sassi I, Baratti D, Gini P, Zito F, Cristallo M, et al: Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits. Dis Col Rect 1994; 37:335-343.
44. 44 Hnatowich DJ, Virzi F, Rusckowski M: Investigations of avidin and biotin for imaging applications. J Nucl Med 1987; 28:1284.
45. 45 Sung C, Van Osdol WW: Pharmocokinetic comparison of direct antibody targeting with pre-targeting protocols based on streptavidin-biotin binding. J Nucl Med 1995; 36:867-876.
46. 46 Saga T, Weinstein JN, Jeong JM, et al: Two-step targeting of experimental lung metastasis with biotinylated antibody and radiolabeled streptavidin. Cancer Res 1994; 54:2160-2165.
47. 47 Paganelli G, Magnani P, Zito F, et al: Three-step monoclonal antibody tumour targeting in CEA-positive patients. Cancer Res 1991; 51:5960-5966.
48. 48 Arnold MA, Schneebaum S, Berens A, et al: Intraoperative detection of colorectal cancer with radioimmunoguided surgery (RIGS) and CC49, a second-generation monoclonal antibody (MAb). Ann Surg 1992; 216:627-632.
49. 49 Cote RJ, Houchens DP, Hitchkock CL, Saad AD, Nines RG, Greenson JK, Schneebaum S, Arnold MW, Martin EW: Intraoperative detection of occult colon cancer micrometastasis using 125-I-radiolabeled monoclonal antibody CC49. Cancer 1996; 77:613-620.
50. 50 Houchens D, Cote R, Saad A, et al: Presence of occult tumor detected by injected I-125 labeled monoclonal antibody CC49. Proc. of the 83rd Annual meeting of the American Association for Cancer Research, 1992; p. 317.
51. 51 Schwartz B, Bresalier RS, Young SK: The role of mucin in colon-cancer metastasis. Int J Cancer 1992; 52:60-65.
52. 52 Gold DV, Mattes ML: Monoclonal antibody B72.3 reacts with a core region structure of O-linked carbohydrates. Tumor Biol 1988; 9:137-144.
53. 53 Cornelius EA, West AB: False tumor-positive lymph nodes in radioimmunodiagnosis and radioimmunoguided surgery: etiologic mechanisms. J Surg Oncol 1996: 63:23-35.
54. 54 Triozzzi PL, Kim JA, Aldrich W, et al: Localization of tumor-reactive, lymph nodes in colorectal cancer patients. I. Flow cytometric analysis of lymphocyte subpopulation. J Surg Oncolog 1991; 46:110-116.
55. 55 Loy TS, Haege DD: B72.3 immunoreactivity in benign abdominal lymph nodes associated with gastrointestinal disease. Dis Col Rect 1995; 38:983-987.
56. 56 Stephens AD, Punja U, Sugarbaker PH: False positive Lymph nodes by radioimmunoguided surgery: report of a patient and analysis of the problem. J Nucl Med 1993; 34:804-808.
57. 57 Patt DJ, Brynes RK, Vardiman JW, et al: Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: An immunomorphic study. Cancer 1975; 35:1388-1397.
58. 58 Quinlan D, Davidson A, Gamponia E et al: Detection of tumor-associated glycoprotein-72 (TAG-72) in short-term and long-term surviving colon cancer patients using a first-and second-generation monoclonal antibody. Proc Am Assoc Cancer Res 1991; 32:271.
59. 59 Schneebaum S, Arnold MW, Houchens D, et al: The importance of intraoperative periportal lymph nodes metastasis identification. Cancer 1995; 75:2809-2817.
60. 60 Mc Guire WL: Breast cancer prognosis: Evaluation guidelined. J Natl Cancer Inst 1991; 83:154-155.
61. 61 Arnold MW, Young DC, Hitchcock CL, Schneebaum S, Martin EW: Radioimmunoguided surgery in primary colorectal carcinoma: An intraoperative prognostic tool and adjuvant to traditional staging. Am J Surg 1995; 170:315-318.
62. 62 Martin EW, Mojzisik CM, Hinkle GH, et al: Radioimmunoguided surgery using monoclonal antibody. Am J Surg 1988; 156:386-392.
63. 63 Martin EW, Carey LC: Second-look surgery for colorectal cancer. Ann Surg 1991; 214:321-327.
64. 64 Bertsch DJ, Arnold MW, Martin EW: Radioimmunoguided surgery (RIGS) improves survival for recurrent colorectal cancer. Abstract Central Surgical Association Cleveland, OH, 1995.
65. 65 Bertsch DJ, Martin EW: Radioimmunoguided surgery (RIGS) challenges the traditions of colorectal cancer surgery. Abstract ASSO Boston, 1995.
66. 66 Steele GD, Bleddy R, Mayer RJ, Lindblud A, Petrelli N, Weaver D: A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: gastrointestinal tumor study group protocol 6584. J Clin Oncol 1991; 9:1105-1112.
67. 67 Hitchcock CL: Radioimmunoguided surgery and the staging of colorectal carcinoma - Seminars in Colo & Rectal Surgery 1995; 6:207-216.
68. 68 Liu BG, Xu GX, Zhang MY: A clinical trial of radioimmunoguided surgery for gastric cancer. Chung Hua Chunbg Liu Tsa Chih 1994; 16:284-287.
69. 131 labeled monoclonal antibody 3H11. Semin Surg Oncol 1994; 10:88-94.
70. 70 Sickle-Santenello BJ, O'Dwyer PJ, Mojzisik C, et al: Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors. Dis Col Rect 1987; 30:761-764.
71. 71 Nieroda CA, Mojzisik C, Sardi A, Ferrara P, Hinkle G, Thurston MO, Martin EW: The impact of radioimmunoguided surgery (RIGS) on surgical decision-making in colorectal cancer. Dis Col Rect 1989; 32:927-932.
72. 72 Sardi A, Workman M, Mojzisik C, Hinkle G, Nieroda C, Martin EW: Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system). Arch Surg 1989; 124:55-59.
73. 73 Cohen AM, Martin EW Jr., Lavery I, et al: Radioimmunoguided surgery using iodine 125I B72.3 in patients with colorectal cancer. Arch Surg 1991; 126:349-351.
74. 74 Di Carlo V, Stella M, De Nardi P, Fazio F: Radioimmunoguided surgery: clinical experience with different monoclonal antibodies and methods. Tumori 1995; 81:98-102.
75. 75 Schneebaum S, Papo J, Graif M, Baratz M, Baron J, Skornik: The efficacy of RIGS (Radioimmunoguided surgery) for colorectal cancer surgery. Abstract ECCO Paris, 1995.
76. 76 Dawson PM, Blair SD, Begent RH, Kelly AM, Boxer GM, Theodorou NA: The value of radioimmunoguided surgery in first and second look laparotomy for colorectal cancer. Dis Col Rect 1991; 34:217-222.
77. 77 Nieroda C, Mojzisik C, Sardi A, Ferrara P, Hinkle G, Thurston MO, Martin EW: Radioimmunoguided surgery in primary colon cancer. Cancer Detect Prev 1990; 14:651-656.
78. 78 Arnold MW, Schneebaum S, Berens A, Mojzisik C, Hinkle G, Martin EW: Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery 1992; 112:624-630.